Boban, Mirta and Babić Leko, Mirjana and Miškić, Terezija and Hof, Patrick R. and Šimić, Goran (2019) Human neuroblastoma SH-SY5Y cells treated with okadaic acid express phosphorylated high molecular weight tau-immunoreactive protein species. Journal of Neuroscience Methods, 319. pp. 60-68. ISSN 0165-0270
|
PDF
- Accepted Version
Download (1MB) |
Abstract
Background: Early stages of Alzheimer's disease (AD) are characterized by high phosphorylation of microtubule-associated protein tau, which may result from the downregulation of protein phosphatases. ----- New method: In order to model phosphatase downregulation and analyze its effect on tau aggregation in vitro, we treated neuroblastoma SH-SY5Y cells with okadaic acid (OA), a protein phosphatase inhibitor, and examined high molecular weight phospho-tau species. ----- Results and comparison with existing methods: OA treatment led to the appearance of heat-stable protein species with apparent molecular weight around 100 kDa, which were immunoreactive to anti-tau antibodies against phosphorylated Ser202 and Ser396. As these high molecular weight tau-immunoreactive proteins (HMW-TIPs) corresponded to the predicted size of two tau monomers, we considered the possibility that they represent phosphorylation-induced tau oligomers. We attempted to dissociate HMW-TIPs by urea and guanidine, as well as by alkaline phosphatase treatment, but HMW-TIPs were stable under all conditions tested. These characteristics resemble properties of certain sodium dodecyl sulfate (SDS)-resistant tau oligomers from AD brains. The absence of HMW-TIPs detection by anti-total tau antibodies Tau46, CP27 and Tau13 may be a consequence of epitope masking and protein truncation. Alternatively, HMW-TIPs may represent previously unreported phosphoproteins cross-reacting with tau. ----- Conclusions: Taken together, our data provide a novel characterization of an OA-based cell culture model in which OA induces the appearance of HMW-TIPs. These findings have implications for further studies of tau under the conditions of protein phosphatase downregulation, aiming to explain mechanisms involved in early events leading to AD.
| Item Type: | Article | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MeSH: | Alzheimer Disease / enzymology ; Antibodies ; Cell Line, Tumor ; Enzyme Inhibitors / administration & dosage ; Humans ; Models, Biological ; Okadaic Acid / administration & dosage ; Phosphoprotein Phosphatases / antagonists & inhibitors ; Phosphoprotein Phosphatases / metabolism ; Phosphorylation ; Radioimmunoprecipitation Assay ; tau Proteins / immunology ; tau Proteins / metabolism | ||||||||||||
| Departments: | Hrvatski institut za istraživanje mozga Katedra za neurologiju |
||||||||||||
| Depositing User: | Kristina Berketa | ||||||||||||
| Status: | Published | ||||||||||||
| Creators: |
|
||||||||||||
| Date: | 1 May 2019 | ||||||||||||
| Date Deposited: | 05 Oct 2020 09:31 | ||||||||||||
| Last Modified: | 05 Oct 2020 09:31 | ||||||||||||
| Subjects: | / | ||||||||||||
| Related URLs: | |||||||||||||
| URI: | http://medlib.mef.hr/id/eprint/3679 |
Actions (login required)
![]() |
View Item |
Downloads
Downloads per month over past year
